Seeking Alpha

More on McKesson (MCK +3.5%) Q3: net profit +35% to $401M, boosted by a strong performance at...

More on McKesson (MCK +3.5%) Q3: net profit +35% to $401M, boosted by a strong performance at its U.S. pharmaceutical distribution business. The company also benefits from the introduction of generic drugs as patents expires across the industry. Raises low end of FY adjusted EPS by 10 cents to $7.15-$7.35 vs consensus of $7.26. (PSS acquisition)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|